Menezes Pharmaceuticals Limited
About Menezes Pharmaceuticals Limited
Data last updated:
Menezes Pharmaceuticals Limited is a public limited company based in Panjim, Goa, India, a subsidiary of Menezes Remedies Limited. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 16 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24232GA1996PLC002040. Its GSTIN is 30AABCC2278C1ZC (Goa). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹85 Lakh. It was formerly known as Cosme Pharma Limited. It is led by directors including Maryann Veronica Menezes and Christine Stephanie Menezes (Nodal Officer).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5th Floor Dempo Towers Edc Patto Plaza, Panjim, Goa, India – 403001.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.15 Cr, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹4.44 Cr (net margin 25.9%) and EBITDA of ₹5.58 Cr (EBITDA margin 32.5%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 12% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has satisfied charges of ₹15.79 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address5th Floor Dempo Towers Edc Patto Plaza, Panjim, Goa, India – 403001
- IndustryFinancial Services, Brokerage & Trading Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Menezes Pharmaceuticals Limited
The main business activity of Menezes Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Menezes Pharmaceuticals Limited FY 2025 filings available
Menezes Pharmaceuticals Limited reported revenue of ₹17.15 Cr (up 79% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Menezes Pharmaceuticals Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 79% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Menezes Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.58 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.44 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Menezes Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 25.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Menezes Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals Limited is compared with the companies closest to it by revenue in the BFSI industry (Broking Services, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Accolade Holdings Private Limited | ₹17.2 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | New Delhi, Delhi, India |
| Indus Shareshree Private Limited | ₹17.19 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Rohtak, Haryana, India |
| Amrapali Aadya Trading and Investment Private Limited | ₹17.18 Cr (FY 2016) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
| Wallfort Share and Stock Brokers Private Limited. | ₹17.18 Cr (FY 2025) | •••• | •••• | 110.0% | •••• | Mumbai, Maharashtra, India |
| Bhushan Pharmaceuticals Private Limited | ₹17.18 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Delhi, India |
| Menezes Pharmaceuticals Limited this company | ₹17.15 Cr (FY 2025) | •••• | •••• | 79.0% | •••• | Panjim, Goa, India |
| Wayonext Pharmaceuticals Private Limited | ₹17.13 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Kalyan, Maharashtra, India |
| Shri Brij Securities Private Limited | ₹17.12 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Mumbai, Maharashtra, India |
| Nilsan Pharmaceuticals Private Limited | ₹17.12 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Amam Investment Pvt Ltd | ₹17.08 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Ahmedabad, Gujarat, India |
| Sagent Pharmaceuticals Private Limited | ₹17.08 Cr (FY 2025) | •••• | •••• | 434.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Menezes Pharmaceuticals by revenue in the BFSI industry (Broking Services, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals Limited is audited by S R KENKRE & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S R KENKRE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maryann Veronica Menezes Also directs: CFL Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Director | 25 Apr 2006 | 20 Years 5 Months | Current |
| Christine Stephanie Menezes Also directs: CFL Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Nodal Officer | 23 Dec 2025 | 0 Years 9 Months | Current |
| Brenda Juliette Nazareth Menezes Also directs: CFL Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Director | 30 Oct 2013 | 12 Years 11 Months | Current |
| Peter Mark Menezes Also directs: Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited, Menezes Remedies Limited and 1 more | Additional Director | 18 Dec 2025 | 0 Years 9 Months | Current |
Ownership and Shareholding of Menezes Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Menezes Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2006 | Bank of India | ₹3.45 Cr | Satisfied |
| 16 Mar 2006 | Bank of India | ₹4.17 Cr | Satisfied |
| 11 Apr 1998 | Bank of India | ₹4.17 Cr | Satisfied |
| 11 Feb 1998 | Bank of India | ₹1 Cr | Satisfied |
| 18 Dec 1997 | Bank of India | ₹2 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals Limited has a workforce of 0 employees as of Mar 31, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Cosme Bio-Tech Private Limited | U31200GA1997PTC002440 | Locked |
Showing major subsidiaries. Total: 1.
Recent Activity on Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals Limited has 11 board changes on record since 2006: 4 appointments and 7 cessations. The latest: Christine Stephanie Menezes was appointed as Nodal Officer on 23 Dec 2025.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Menezes Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Menezes Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Menezes Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 30AABCC2278C1ZC | Goa | Active | 01 Jul 2017 |
| 24AABCC2278C1Z5 | Gujarat | Active | 16 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Menezes Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Menezes Pharmaceuticals Limited
Menezes Pharmaceuticals is an active public limited company based in Panjim, Goa, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 16 February 1996 (30+ years old) and is registered under CIN U24232GA1996PLC002040.
Menezes Pharmaceuticals reported revenue of ₹17.15 Cr for FY 2025 (up 79% YoY).
Menezes Pharmaceuticals has 4 current directors:
- Maryann Veronica Menezes - Director
- Brenda Juliette Nazareth Menezes - Director
- Peter Mark Menezes - Additional Director
- Christine Stephanie Menezes - Nodal Officer
Menezes Pharmaceuticals reported a net profit of ₹4.44 Cr (net margin 25.9%) and EBITDA of ₹5.58 Cr (EBITDA margin 32.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Menezes Pharmaceuticals is 12% over three years and 12% over five years. In the latest year (FY 2025) revenue rose 79%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Menezes Pharmaceuticals is 30AABCC2278C1ZC, registered in Goa. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AABCC2278C1Z5 (Gujarat).
The CIN (Corporate Identification Number) of Menezes Pharmaceuticals is U24232GA1996PLC002040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Menezes Pharmaceuticals was incorporated on 16 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Menezes Pharmaceuticals by revenue are Accolade Holdings Private Limited, Indus Shareshree Private Limited, Amrapali Aadya Trading and Investment Private Limited, Wallfort Share and Stock Brokers Private Limited, Bhushan Pharmaceuticals Private Limited and 5 more, all in the BFSI industry (Broking Services, Pharmaceuticals).
Christine Stephanie Menezes was appointed as Nodal Officer on 23 Dec 2025. Peter Mark Menezes was appointed as Additional Director on 18 Dec 2025. Andre Jose Joao De Menezes ceased to be Director on 06 Jan 2017. Menezes Pharmaceuticals has 11 board changes on record in total.
The registered office of Menezes Pharmaceuticals is at 5th Floor Dempo Towers Edc Patto Plaza, Panjim, Goa, India – 403001.